Michael Cass

A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone Prior to Allogeneic Stem Cell Transplantation

Y. Landesman, T. Kashyap, A. McDonald, 2022, The American journal of case reports.

Is Haploidentical Haematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide (PTCY) Feasible In Sub-Saharan Africa?

E. Verburgh, M. Seftel, V. Louw, 2021, Transplantation and cellular therapy.